Cargando…
Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356827/ https://www.ncbi.nlm.nih.gov/pubmed/37468494 http://dx.doi.org/10.1038/s41467-023-40050-1 |
| _version_ | 1785075361000718336 |
|---|---|
| author | Hill, Richard Madureira, Patricia A. Ferreira, Bibiana Baptista, Inês Machado, Susana Colaҫo, Laura dos Santos, Marta Liu, Ningshu Dopazo, Ana Ugurel, Selma Adrienn, Angyal Kiss-Toth, Endre Isbilen, Murat Gure, Ali O. Link, Wolfgang |
| author_facet | Hill, Richard Madureira, Patricia A. Ferreira, Bibiana Baptista, Inês Machado, Susana Colaҫo, Laura dos Santos, Marta Liu, Ningshu Dopazo, Ana Ugurel, Selma Adrienn, Angyal Kiss-Toth, Endre Isbilen, Murat Gure, Ali O. Link, Wolfgang |
| author_sort | Hill, Richard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10356827 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103568272023-07-21 Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT Hill, Richard Madureira, Patricia A. Ferreira, Bibiana Baptista, Inês Machado, Susana Colaҫo, Laura dos Santos, Marta Liu, Ningshu Dopazo, Ana Ugurel, Selma Adrienn, Angyal Kiss-Toth, Endre Isbilen, Murat Gure, Ali O. Link, Wolfgang Nat Commun Retraction Note Nature Publishing Group UK 2023-07-19 /pmc/articles/PMC10356827/ /pubmed/37468494 http://dx.doi.org/10.1038/s41467-023-40050-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Retraction Note Hill, Richard Madureira, Patricia A. Ferreira, Bibiana Baptista, Inês Machado, Susana Colaҫo, Laura dos Santos, Marta Liu, Ningshu Dopazo, Ana Ugurel, Selma Adrienn, Angyal Kiss-Toth, Endre Isbilen, Murat Gure, Ali O. Link, Wolfgang Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT |
| title | Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT |
| title_full | Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT |
| title_fullStr | Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT |
| title_full_unstemmed | Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT |
| title_short | Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT |
| title_sort | retraction note: trib2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase akt |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356827/ https://www.ncbi.nlm.nih.gov/pubmed/37468494 http://dx.doi.org/10.1038/s41467-023-40050-1 |
| work_keys_str_mv | AT hillrichard retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT madureirapatriciaa retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT ferreirabibiana retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT baptistaines retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT machadosusana retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT colaҫolaura retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT dossantosmarta retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT liuningshu retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT dopazoana retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT ugurelselma retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT adriennangyal retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT kisstothendre retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT isbilenmurat retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT gurealio retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt AT linkwolfgang retractionnotetrib2confersresistancetoanticancertherapybyactivatingtheserinethreonineproteinkinaseakt |